禾元生物：本次质押完成后，上海同盛累计质押公司股份1173万股

Group 1 - Core viewpoint: He Yuan Bio announced that as of the disclosure date, its shareholder Shanghai Tongsheng Yongying Enterprise Management Center holds approximately 20.08 million shares, accounting for 5.62% of the total share capital [1] - After the completion of the pledge, the total pledged shares amount to 11.73 million, representing 58.4% of the shareholder's total holdings and 3.28% of the company's total share capital [1] - As of the report date, He Yuan Bio's market capitalization is 25.8 billion yuan [1] Group 2 - For the first half of 2025, He Yuan Bio's revenue composition shows that recombinant human serum albumin accounts for 75.44%, other products account for 18.76%, and other businesses account for 5.8% [1]